We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.08 | -0.18% | 43.42 | 43.64 | 43.175 | 43.63 | 966,800 | 18:33:28 |
Name of applicant:
|
GSK plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2012
|
|||
Period of return:
|
From:
|
1 May 2022
|
To:
|
31 October 2022
|
Balance of unallotted securities under scheme(s) from previous
return:
|
1,373,495
|
|||
Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for):
|
0
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
251,620
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
1,121,875
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
|
GSK plc
|
|
(Registrant)
|
|
|
Date: November
15, 2022
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions